330216-62-1 Usage
General Description
Methyl 2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxylate is a chemical compound with a complex molecular structure. It is a derivative of pyridine and contains a methyl ester group, a trifluoromethylphenyl group, and a carboxylate group. METHYL 2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE is commonly used in organic synthesis and pharmaceutical research due to its potential as a building block for the development of new drugs and pharmaceuticals. It may also have applications in pesticide and agrochemical production. The specific properties and potential uses of this compound may vary depending on its formulation and purity.
Check Digit Verification of cas no
The CAS Registry Mumber 330216-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,0,2,1 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 330216-62:
(8*3)+(7*3)+(6*0)+(5*2)+(4*1)+(3*6)+(2*6)+(1*2)=91
91 % 10 = 1
So 330216-62-1 is a valid CAS Registry Number.
330216-62-1Relevant articles and documents
Development of dihydropyridone indazole amides as selective rho-kinase inhibitors
Goodman, Krista B.,Cui, Haifeng,Dowdell, Sarah E.,Gaitanopoulos, Dimitri E.,Ivy, Robert L.,Sehon, Clark A.,Stavenger, Robert A.,Wang, Gren Z.,Viet, Andrew Q.,Xu, Weiwei,Ye, Guosen,Semus, Simon F.,Evans, Christopher,Fries, Harvey E.,Jolivette, Larry J.,Kirkpatrick, Robert B.,Dul, Edward,Khandekar, Sanjay S.,Yi, Tracey,Jung, David K.,Wright, Lois L.,Smith, Gary K.,Behm, David J.,Bentley, Ross,Doe, Christopher P.,Hu, Erding,Lee, Dennis
, p. 6 - 9 (2007/10/03)
Rho kinase (ROCK1) mediates vascular smooth muscle contraction and is a potential target for the treatment of hypertension and related disorders. Indazole amide 3 was identified as a potent and selective ROCK1 inhibitor but possessed poor oral bioavailabi
